the utility of a dual-sample strategy leveraging environmental aircraft wastewater and pooled nasal swab Methods: Using a combined pooled nasal swab and aircraft wastewater sampling approach resulted in complementary Results: Mutational profiling in source pooled nasal swabs and aircraft wastewater sample data revealed Emerging variant JN.1 was detected early in nasal swab data, demonstrating the power of using genomic detection of SARS-CoV-2 variants using genomic surveillance: insights from aircraft wastewater and nasal swabs

Microbiome A Particles and skim milk workflows coupled with MagMax kit) for SARS-CoV-2 recovery in Moore swab viral concentration significantly improved viral concentration results (P < 0.0001) in 10 mL grab and swab SARS-CoV-2 concentrations in 10 mL grab and Moore swab samples with ER1 processed by the automated workflow higher (P < 0.001) results than 150 mL grab samples using the membrane filtration workflow and 250 mL swab

hydrogel particle enabled workflow for capturing and concentrating SARS-CoV-2 from diagnostic remnant swab

samples were collected from three Wastewater Treatment Plants (WWTPs) using a 24-h composite Moore swab

this sample preparation strategy was applied to pooled samples originating from nasopharyngeal (NP) swabs

In a double-blind study analyzing viral transport media (VTM) obtained from clinical nasopharyngeal swabs

Notably, we successfully analyzed full-process controls, positive clinical nasopharyngeal swabs suspended

Notably, we successfully analyzed full-process controls, positive clinical nasopharyngeal swabs suspended

subtypes of Influenza virus, Coronavirus, and Respiratory Syncytial Virus from saliva, nasal fluid swab